Insights

Advancing the science and practice of sleep medicine through evidence-based insights and data-driven analysis.

insights
Filter
filter
Category
Content type

Too late by design: RLS guidelines outpace the system

Clinical guidelines for restless legs syndrome (RLS) have evolved. The system meant to support patients living with this disease has not.

OSA in women: What are we doing wrong?

Male-based models overlook how OSA presents in women. Phenotyping shows why severity scoring misses risk and delays effective care.

Sleep and mental health: The importance of connected clincal practice

Sleep and mental health are strongly intertwined, yet care remains siloed. Collaborative care pathways can close gaps, reduce misdiagnosis and strengthen outcomes.

The missing link: Re-engagement and continuity in OSA care

OSA is chronic yet care systems treat drop-off as an endpoint. Re-engagement and continuity pathways are essential to improving outcomes and reducing inequities.

Reimbursement for OSA care must move beyond short-term compliance to continuity

Treatment adherence is not merely a patient behavior but a direct outcome of health policy and reimbursement design. Sustainable OSA therapy requires payment models that enable long-term, individualized care.

Adherence by design: Redesigning payment models to sustain OSA therapy

Treatment adherence is a policy outcome, not patient behavior. Reimbursement frameworks and payment incentives ultimately determine whether treatment persists.

Emerging treatments shaping insomnia and COMISA care

Dr. Sweetman explores new insomnia and COMISA treatments and shares his future research path toward better COMISA care access and delivery.

CBT-I access limited by reimbursement gaps and workforce shortages

Dr. Sweetman explores how reimbursement gaps and workforce shortages drive over-reliance on medication over CBT-I in insomnia care.

Why COMISA needs strategic primary care education

Dr. Sweetman shares how COMISA care can improve with strategic GP education, cross-specialty collaboration and increased CBT-I access.

Why the OSA journey needs long-term, adaptive treatment models

OSA is chronic and affects nearly a billion people, yet care remains rigid and binary. It’s time for a model that’s flexible and supports long-term care.

The Swedish OSA treatment matrix: Implementation lessons

Professor Grote reflects on the clinical reception, implementation and impact of the Swedish OSA treatment matrix since its 2021 rollout.

Symptoms and comorbidities in the Swedish treatment matrix

Professor Grote explains how symptoms and comorbidities are evaluated within the context of the Swedish treatment matrix.

Registries shaping sleep apnea care in Europe

Professor Grote discusses the role of national and European registries in advancing sleep apnea care.

The scale and strain of OSA and delays in access to care

Professor Grote sheds light on the rising demand for OSA treatment and the attendant strain on health systems.

Primary-specialty care pathway pilot targets wait time reduction for OSA care

Professor Grote discusses how involving general practitioners more directly in OSA care could help improve access to timely OSA care.

Underdiagnosed and overlooked:The OSA challenge

OSA is a prevalent yet underdiagnosed disease, currently affecting over 50 million adults in the United States, yet up to 80% of cases remained undiagnosed1, 2 — demanding urgent action to close the care gap.

The economic value of treating OSA with PAP therapy

By reducing acute care costs and improving management of high-cost comorbidities, PAP therapy offers a compelling opportunity to reduce total cost of care.

Action needed to navigate the rising tide of OSA

Immediate action is needed by multiple sleep stakeholders to ensure the future burden of OSA can be clinically managed by sleep specialists and primary care providers (PCPs)

Rethinking OSA screening and diagnosis in women

Hear from Dr. Jonna Morris about diagnostic and screening blind spots surrounding women and OSA.

Diagnostic blind spots: How OSA presents differently in women

Dr. Jonna Morris explains how language and reporting patterns affect OSA presentation in women, and why many remain overlooked.

Sleep care reform is long overdue

Making sleep essential requires more than recognition—it demands policy, funding, and clinical integration across systems of care.

The high price of ignoring sleep

Recognizing sleep as essential marks progress, but real-world change in care delivery, education, and funding remains critically overdue.

What's next for the Baveno classification?

Hear from Prof. Winfried Randerath about the adoption of the Baveno classification into clinical practice and the role of primary care in that.

How the Baveno classification impacts key patient groups

Hear from Prof. Winfried Randerath what impact the modified Baveno classification has for women, people with mild OSA and others.

AHI's evolving role in the modified Baveno classification

Hear from Prof. Winfried Randerath how and why AHI has been added to the modified Baveno classification and its impact on patients.

Professor Winfried Randerath and the modified Baveno classification

Hear from Prof. Winfried Randerath how the Baveno classification has been modified to more effectively categorize patients with sleep apnea.

A call to invest in rest: Better sleep improves mental health

Along with the economy, productivity and health systems, we must invest in rest as a serious policy principle. It is that integral to our health.

Beyond AHI: The search for more robust OSA diagnostic criteria

AHI as the sole or primary OSA diagnostic criteria puts too many people at risk by preventing treatment for those who need it.

How AHI came to be the standard diagnostic measure

The AHI and OSA are deeply intertwined, but questions have been asked about AHI as a metric of OSA diagnosis and classification from the beginning.

Beyond the stereotypes: Obstructive sleep apnea in women

A growing body of research shows how gender biases and stereotypes of obstructive sleep apnea stand in the way of women receiving the help they need.

The insufficiency of today's approach to COMISA care

Despite clear recognition as a standalone condition, COMISA remains not only underdiagnosed but poorly managed, falling through many systemic cracks.

The increasing burden of insomnia and COMISA

Clinicians, policymakers and industry leaders must give greater attention to the impact of COMISA on individuals, health systems and economies.

COMISA: The underdiagnosis continues

As comorbid insomnia and OSA (COMISA) is recognized as a standalone condition, diagnostic approaches lack, resulting in high rates of underdiagnosis.

CBT-I addresses root causes of insomnia, not just symptoms

CBT-I ushers in a new level of promise for patients with insomnia as a true treatment that is non-invasive and free of pharmacological interactions.

How P4 medicine can improve diagnosis and treament of OSA

Current approaches to OSA leave many struggling, often going undiagnosed and untreated. A P4 mindset can shift thinking to identify at-risk patients earlier.

The value of clinical trial and real-world data together

RWE with RCTs blends theory with practice to increase patient representation and identify long-term trends, enhancing the ability to advance patient care.

No result found
scroll-to-top

Privacy|Terms of use |©2026 Resmed|All rights reserved